LeMaitre Vascular Inc (LMAT) stock news · P/E 28, rev $249.6M
LeMaitre Vascular Inc (LMAT) is a medical instruments & supplies company listed on US.
This LMAT news page leads with what LeMaitre Vascular Inc filed — not a scraped headline mill.
No cached 8-K sentence for LMAT yet. We will not pad this page with generic market recap.
Latest reported LMAT revenue for 2025-12-31 was $249.6M. Net income was $57.7M. Revenue was up 13.5% from 2024-12-31 to 2025-12-31. LMAT currently screens at market cap $2.16B and trailing P/E 28.3.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the LMAT stock page; for the tape open the quote page.
LMAT stock news FAQ
What are LMAT's latest revenue and net income?
Latest cached LeMaitre Vascular Inc (LMAT) revenue for Dec 31, 2025 was $249.6M. Net income was $57.7M. Statements: https://lician.com/financials/lmat
How did LMAT revenue change from the prior cached period?
Cached LeMaitre Vascular Inc (LMAT) revenue was up 13.5% from $219.9M (Dec 31, 2024) to $249.6M (Dec 31, 2025). Statements: https://lician.com/financials/lmat
What is LMAT's P/E ratio?
LeMaitre Vascular Inc (LMAT) trailing P/E is 28.3 on the latest cached fundamentals snapshot.
What is LMAT's market cap?
LeMaitre Vascular Inc (LMAT) market cap is $2.16B on the latest cached fundamentals snapshot.
What kind of company is LMAT?
LeMaitre Vascular Inc (LMAT) is a medical instruments & supplies company listed on US.
Where is LMAT stock news listed?
Cached stock news for LeMaitre Vascular Inc (LMAT) is listed at https://lician.com/news/lmat. Filings: https://lician.com/sec/lmat
Not investment advice.